ANDA 74600, held by Watson Labs. Clomipramine Hydrochloride.
As of Nov 16, 2026, ANDA 74600 (Clomipramine Hydrochloride), held by Watson Labs, was first approved by FDA on Nov 27, 1996, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 27, 1996 | Original application | Approved | None posted |
| Clomipramine Hydrochloride25MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride50MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride75MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Sep 10, 2002 | Supplement 5Labeling | Approved | None posted |
| Sep 28, 2001 | Supplement 4Manufacturing | Approved | None posted |
| May 18, 2000 | Supplement 3Labeling | Approved | None posted |
| Aug 24, 1999 | Supplement 2Labeling | Approved | None posted |
| Mar 6, 1998 | Supplement 1Labeling | Approved | None posted |
| Nov 27, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters